0
0

Chapter 34. Treatment of Children and Adolescents

Margery Johnson, M.D.; Nicholas Hatzis, M.D.; Mina Dulcan, M.D.; Glen Crawford, M.D.; Stephen Cozza, M.D.
DOI: 10.1176/appi.books.9781585625031.026621

Sections

Excerpt

In this chapter we focus on psychiatric treatments for children and adolescents and how they differ from treatment of adults. Expanding research has led to more specific empirically tested interventions for youth. Childhood psychopathology and disorder-specific treatments are discussed in Part II (see, e.g., Chapter 8, “Neurodevelopmental Disorders”). Throughout this chapter, unless otherwise stated, the terms child and children include adolescents. Parent is used for the parent, guardian, or responsible adult. The goals of all treatments are to reduce symptoms, to improve emotional and behavioral functioning, to remedy skill deficits, and to remove obstacles to normal development. In contrast to the treatment of adults, a child is usually brought by someone else, and in each case there are at least two clients, the parent and the child, whose perceptions of the problem and goals for treatment often conflict. Compared with adults, children are more dependent on others for meeting their basic needs, they have fewer choices of residence or activities, and they are required to attend school.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Anchor for Jump
Stimulant preparations
Anchor for Jump
Side effects of stimulant medications
Anchor for Jump
Dosing guidelines for second-generation antipsychotic agents
Anchor for Jump
Family tasks

References

Abnormal Involuntary Movement Scale (AIMS). Psychopharmacol Bull 24:781–783, 1988
[PubMed]
 
Alexander JF: An integrative model for treating the adolescent who is delinquent/acting out, in Empowering Families, Helping Adolescents: Family Centered Treatment of Adolescents With Alcohol, Drug Abuse, and Mental Health Problems. Edited by Snyder W, Oooms T. Rockville, MD, U.S. Department of Health and Human Services, 1992, pp 101–110
 
Allen AJ, Kurlan RM, Gilbert DL, et al: Ato-mox-etine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 65:1941–1949, 2006
[PubMed]
 
Aman MG, De Smedt G, Derivan A, et al: Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159:1337–1346, 2002
[PubMed]
 
Aman MG, Arnold LE, Ramadan Y, et al: Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62:1266–1274, 2005
[PubMed]
 
Ambrosini PJ, Sheikh RM: Increased plasma valproate concentrations when coadministered with guanfacine. J Child Adolesc Psychopharmacol 8:143–147, 1998
[PubMed]
 
American Academy of Child and Adolescent Psychiatry: Practice parameter for psychodynamic psychotherapy with children. J Am Acad Child Adolesc Psychiatry 51:541–557, 2012
[PubMed]
 
Anderson CM, Hogarty GE, -Reiss DJ: Family treatment of adult schizophrenic patients: a psycho-educational approach. Schizophr Bull 6:490–505, 1980
[PubMed]
 
Arnold LE, Aman MG, Cook AM, et al: Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 45:1196–1205, 2006
[PubMed]
 
Barkley RA: Defiant Children: A Clinician’s Manual for Assessment and Parent Training, 3rd Edition. New York, Guilford, 2013
 
Barrickman LL, Perry PJ, Allen AJ, et al: Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:649–657, 1995
[PubMed]
 
Biederman J, Melmed RD, Patel A, et al: A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics 121:e73–e84, 2008
[PubMed]
 
Birmaher B, Greenhill LL, Cooper TB, et al: Sustained release methylphenidate: pharmacokinetic studies in ADHD males. J Am Acad Child Adolesc Psychiatry 28:768–772, 1989
[PubMed]
 
Blechman EA: Toward comprehensive behavioral family intervention: an algorithm for matching families and interventions. Behav Modif 5:221–236, 1981
 
Brent DA, Birmaher B: British warnings on SSRIs questioned. J Am Acad Child Adolesc Psychiatry 43:379–380, 2004
[PubMed]
 
Brent D, Emslie G, Clarke G, et al.: Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 299:901–913, 2008
[PubMed]
 
Brinkmeyer M, Eyberg SM: Parent-child interaction therapy for oppositional children, in Evidence-Based Psychotherapies for Children and Adolescents. Edited by Kazdin AE, Weisz JR. New York, Guilford, 2003, pp 204–223
 
Brown RT, Sexson SB: Effects of methyl-phen-i-date on cardiovascular responses in attention deficit hyperactivity disordered adolescents. Journal of Adolescent Health Care 10:179–183, 1989
[PubMed]
 
Chorpita BF: Modular Cognitive-Behavioral Therapy for Childhood Anxiety Disorders. New York, Guilford, 2007
 
Clein PD, Riddle MA: Pharmacokinetics in children and adolescents, in Child and Adolescent Psychiatry: A Comprehensive Textbook, 2nd Edition. Edited by Lewis M. Baltimore, MD, Williams & Wilkins, 1996, pp 765–772
 
Coffey BJ, Shader RI, Greenblatt DJ: Pharmacokinetics of benzodiazepines and psychostimulants in children. J Clin Psychopharmacol 3:217–225, 1983
[PubMed]
 
Cohen JA, Mannarino AP, Deb-linger E: Treating Trauma and Traumatic Grief in Children and Adolescents. New York, Guilford, 2006
 
Conners CK, Casat CD, Gual-tieri CT, et al: Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 35:1314–1321, 1996
[PubMed]
 
Cooper W, Habel L, Sox C, et al: ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 365:1896–1904, 2011
[PubMed]
 
Correll CU, Penzner JB, Parikh UH, et al: Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents. Child Adolesc Psychiatric Clin N Am 15:177–206, 2006
[PubMed]
 
DelBello MP, Findling RL, Kushner S, et al: A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:539–547, 2005
[PubMed]15908836
 
DelBello MP, Kowatch RA, Adler CM, et al: A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 45:305–313, 2006
[PubMed]
 
Dion Y, Annable L, Sandor P, et al: Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 22:31–39, 2002
[PubMed]
 
Dulcan MK: Brief psychotherapy with children and their families: the state of the art. J Am Acad Child Psychiatry 23:544–551, 1984
[PubMed]
 
Dulcan MK (ed): Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems: A Resource Book of Medication Information Handouts, 3rd Edition. Washington, DC, American Psychiatric Publishing, 2007
 
Dulcan MK, Piercy PA: A model for teaching and evaluating brief psychotherapy with children and their families. Professional Psychology: Research and Practice 16:689–700, 1985
 
Elia J, Borcherding BG, Rapoport JL, et al: Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res 36:141–155, 1991
[PubMed]
 
Emslie GJ, Heiligenstein JH, Wagner KD, et al: Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41:1205–1215, 2002
[PubMed]
 
Findling RL, McNamara NK, Branicky LA, et al: A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry 39:509–516, 2000
[PubMed]
 
Findling RL, McNamara NK, Gracious BL, et al: Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 42:895–901, 2003
[PubMed]
 
Findling RL, McNamara NK, Youngstrom EA, et al: Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:409–417, 2005
[PubMed]15843762
 
Forehand R, Long N: Parenting the Strong-Willed Child: The Clinically Proven Five-Week Program for Parents of Two- to Six-Year-Olds, Revised and Updated Edition. New York, Contemporary Books, 2002
 
Franklin ME, Sapyta J, Freeman JB, et al: Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA 306:1224–1232, 2011
[PubMed]
 
Geller B, Cooper TB, Sun K, et al: Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 37:171–178, 1998
[PubMed]
 
Geller B, Biederman J, Stewart ES, et al: Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive compulsive disorder. Am J Psychiatry 160:1919–1928, 2003
[PubMed]
 
Geller B, Luby JL, Joshi P, et al: A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry 69:515–528, 2012
[PubMed]
 
Gibbons RD, Brown CH, Hur K, et al: Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry 69:580–587, 2012
[PubMed]
 
Green RW: The Explosive Child: A New Approach for Understanding and Parenting Easily Frustrated, Chronically Inflexible Children. New York, Harper-Collins, 2010
 
Greenhill LL: Attention-deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 4:123–168, 1995
[PubMed]
 
Greenhill LL, Kollins S, Abikoff H, et al: Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45:1284–1293, 2006
[PubMed]
 
Hammerness PG, Perrin JM, Shelley-Abrahamson R, et al: Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations. J Am Acad Child Adolesc Psychiatry 50:978–990, 2011
[PubMed]
 
Harper G: Focal inpatient treatment planning. J Am Acad Child Adolesc Psychiatry 28:31–37, 1989
[PubMed]
 
Hazell PL, Stuart JE: A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry 42:886–894, 2003
[PubMed]
 
Henggeler SW, Cunningham PB, Schoenwald SK, et al: Multisystemic Therapy for Antisocial Behavior in Children and Adolescents. New York, Guilford, 2009
 
Horrigan JP, Barnhill LJ: Guanfacine and secondary mania in children. J Affect Disord 54:309–314, 1999
[PubMed]
 
Hughes CW, Emslie GJ, Crimson ML, et al: Texas Children’s Medication Algorithm Project: update from Texas consensus conference panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry 46:667–686, 2007
[PubMed]
 
Jain R, Segal S, Kollins SH, et al: Clonidine extended–release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 50:171–179, 2011
[PubMed]
 
Jensen PS: Current concepts and controversies in the diagnosis and treatment of attention deficit hyperactivity disorder. Curr Psychiatry Rep 2:102–109, 2000
[PubMed]
 
Kazdin AE:Developing a research agenda for child and adolescent psychotherapy. Arch Gen Psychiatry 57:829–835, 2000
[PubMed]
 
Kazdin AE: The Kazdin Method for Parenting the Defiant Child. New York, Mariner Books, 2009
 
Kelsey DK, Sumner CR, Casat CD, et al: Once-daily atomoxetine treatment of children with ADHD, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics 114:e1–e8, 2004
[PubMed]
 
Knapp P, Chait A, Pappadopulos E, et al: Treatment of maladaptive aggression in youth: CERT guidelines I—engagement, assessment, and management. Pediatrics 129:e1562–e1576, 2012
[PubMed]
 
Kollins SH, Jain R, Brams M, et al: Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics 127:e1406–e1413, 2011
[PubMed]
 
Kowatch R, Findling R, Scheffer R, et al: Placebo controlled trial of divalproex versus lithium for bipolar disorder. Presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry, Boston, MA, October 2007
 
Kratochvil CJ, Wilens TE, Greenhill LL, et al: Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:919–927, 2006
[PubMed]
 
Kratochvil CJ, Vaughan BS, Stoner JA, et al: A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics 127:e862–e868, 2011
[PubMed]
 
Kumra S, Frazier JA, Jacobsen LK, et al: Child-onset schizophrenia: a double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 53:1090–1097, 1996
[PubMed]
 
Kumra S, Jacobsen L, Lenane M, et al: Case series: Spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 37:221–227, 1998
[PubMed]
 
Lewis O: Psychological factors affecting pharmacological compliance. Child Adolesc Psychiatr Clin N Am 4:15–22, 1995
 
Lofthouse N, Hendren R, Hurt E, et al: A review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat 2012:870391, 2012
[PubMed]
 
March JS, Foa E, Gammon P, et al: Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. The Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969–1976, 2004
[PubMed]
 
March JS, Silva S, Vitiello B: The Treatment for Adolescents with Depression Study: methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry 45:1393–1403, 2006
[PubMed]
 
McCracken JT, McGough J, Shah B, et al: Research Units on Pediatric Psychopharmacology Autism Network: Risperidone in children with autism and serious behavioral problems. N Engl J Med 347:314–321, 2002
[PubMed]
 
McCracken JT, Aman MG, -McDougle CJ, et al: Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry 162:1361–1369, 2005
[PubMed]
 
McMahon R, Forehand R: Helping the Noncompliant Child: Family Based Treatment for Oppositional Behavior, 2nd Edition. New York, Guilford, 2003
 
Michelson D, Faries D, Wernicke J, et al: Atomoxetine in the treatment of children and adolescent with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108:e83, 2001
[PubMed]
 
Miller AL, Rathus HK, Linehan MM: Dialectical Behavior Therapy With Suicidal Adolescents. New York, Guilford, 2007
 
Miller WR, Rollnick S: Motivational Interviewing: Preparing People for Change, 2nd Edition. New York, Guilford, 2002
 
MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073–1086, 1999
[PubMed]
 
Mufson L, Dorta KP, Moreau D, et al: Interpersonal Psychotherapy for Depressed Adolescents, 2nd Edition. New York, Guilford, 2004a
 
Mufson L, Dorta KP, Wickramaratne P, et al: A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 61:577–584, 2004b
[PubMed]
 
Newcorn JH, Spencer TJ, Biederman J, et al: Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry 44:240–248, 2005
[PubMed]
 
Newcorn JH, Sallee FR, Pelham WE, et al: Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study. J Am Acad Child Adolesc Psychiatry 48:511–518, 2009
[PubMed]
 
Newman TB: A black box warning for antidepressants in children? N Engl J Med 351:1595–1598, 2004
[PubMed]
 
Olfson M, Huang C, Gerhard T, et al: Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 51:147–156, 2012
[PubMed]
 
Pappadopulos E, MacIntyre JC, Crimson ML, et al: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY), part II. J Am Acad Child Adolesc Psychiatry 42:145–161, 2003
[PubMed]
 
Patterson GR: Families: Applications of Social Learning to Family Life. Champaign, IL, Research Press, 1975
 
Pelham WE, Gnagy EM, Greiner AR, et al: Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychol 28:507–526, 2000
[PubMed]
 
Pelham WE, Massetti GM, Wilson T, et al: Implementation of a comprehensive schoolwide behavioral intervention: the ABC Program. J Atten Disord 9:248–260, 2005
[PubMed]
 
Perrin JM, Friedman R, Knilans TK, et al: Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics 122:451–453, 2008
[PubMed]
 
PhysiciansMedGuide: The Use of Medication in Treating Childhood and Adolescent Depression: Information for Physicians. Prepared by American Psychiatric Association, n.d. Available at: www.parentsmedguide.org/physiciansmedguide.pdf. Accessed July 17, 2013.
 
Pliszka SR, Crismon ML, Hughes CW, et al: The Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:642–657, 2006
[PubMed]
 
Sallee FR, McGough J, Wigal T, et al: Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 48:155–165, 2009
[PubMed]
 
Sallee FR, Connor DF, Newcorn JH: A review of the rationale and clinical utilization of a2-adrenoceptor agonists for the treatment of A-D/H and related disorders. J Child Adolesc Psychopharmacol 23:308–319, 2013
[PubMed]
 
Scahill L, Chappell PB, Kim YS, et al: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067–1074, 2001
[PubMed]
 
Scahill L, Leckman JF, Schultz RT, et al: A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60:1130–1135, 2003
[PubMed]
 
Schelleman H, Bilker WB, Strom BL, et al: Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 127:1102–1110, 2011
[PubMed]
 
Schur SB, Sikich L, Findling RL, et al: Treatment Recommendations for the use of Antipsychotics for Aggressive Youth (TRAAY), part I: a review. J Am Acad Child Adolesc Psychopharmacol 42:132–144, 2003
[PubMed]
 
Scotto Rosato N, Correll CU, Pappadopulos E, et al: Treatment of maladaptive aggression in youth:CERT guidelines II—treatments and ongoing management. Pediatrics 129:e1577–e1586, 2012
[PubMed]
 
Shea S, Turgay A, Carroll A, et al: Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114:634–641, 2004
[PubMed]
 
Snyder R, Turgay A, Aman M, et al: Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry 41:1026–1036, 2002
[PubMed]
 
Sonuga-Barke EJS, Brandeis D, Cortese S, et al: Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170:275–289, 2013
[PubMed]
 
Spencer T, Newcorn JH, Kratochvil CJ, et al: Effects of atomoxetine on growth after 2‑year treatment among pediatric patients with attention-deficit/hyperactivity disorder. Pediatrics 116:e74–e80, 2005
[PubMed]
 
Sprenkle D: Intervention research in couple and family therapy: a methodological and substantive review and an introduction to the special section. J Marital Fam Ther 38:3–29, 2012
[PubMed]
 
Steingard R, Biederman J, Spencer TJ, et al: Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 32:350–353, 1993
[PubMed]
 
Strupp HH: Psychotherapy: Clinical, Research, and Theoretical Issues. New York, Jason Aronson, 1973
 
Sugai G, Horner RH: Introduction to the special series on positive behavior support in schools. J Emot Behav Disord 10:130–136, 2002
[PubMed]
 
Tourette’s Syndrome Study Group: Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 58:527–536, 2002
[PubMed]
 
Vitiello B, Severe JB, Greenhill LL, et al: Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry 40:188–196, 2001
[PubMed]
 
Wagner KD, Kowatch RA, Emslie GJ, et al: A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 163:1179–1186, 2006
[PubMed]
 
Wagner KD, Redden L, Kowatch RA, et al: A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 48:519–532, 2009
[PubMed]
 
Walsh F (ed): Normal Family Processes: Growing Diversity and Complexity, 4th Edition. New York, Guilford, 2012
 
Weiss M, Tannock R, Kratochvil C, et al: A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 44:647–655, 2005
[PubMed]
 
Weisz JR, Jensen AL: Child and adolescent psychotherapy in research and practice contexts: review of the evidence and suggestions for improving the field. Eur Child Adolesc Psychiatry 10 (suppl 1):I/12–I/18, 2001
[PubMed]
 
Weller EB, Weller RA, Fristad MA: Lithium dosage guide for prepubertal children: a preliminary report. J Am Acad Child Psychiatry 25:92–95, 1986
[PubMed]
 
Whalen EH, Henker B: Social impact of stimulant treatment for hyperactive children. J Learn Disabil 24:231–241, 1991
[PubMed]
 
Wigal S, McGough J, McCracken JT, et al: A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. J Atten Disord 9:275–289, 2005
[PubMed]
 
Wilens TE, Biederman J, Kwon A, et al: A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol 13:143–152, 2003
[PubMed]
 
Wilens TE, Bukstein O, Brams M, et al: A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 51:74–85, 2012
[PubMed]
 
Wolraich ML, Wilson DB, White JW: The effect of sugar on behavior or cognition in children: a meta-analysis. JAMA 274:1617–1621, 1995
[PubMed]
 
Wolraich ML, Feurer I, Hannah JN, et al: Obtaining systematic teacher reports of disruptive behavior disorders utilizing DSM-IV. J Abnorm Child Psychol 26:141–152, 1998
[PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 36.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 2.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 3.  >
Topic Collections
Psychiatric News
PubMed Articles
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation